Biodesix (NASDAQ: BDSX)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Biodesix (NASDAQ: BDSX) through any online brokerage.
The latest price target for Biodesix (NASDAQ: BDSX) was reported by Morgan Stanley on Thursday, May 12, 2022. The analyst firm set a price target for 5.00 expecting BDSX to rise to within 12 months (a possible 270.37% upside). 3 analyst firms have reported ratings in the last year.
The stock price for Biodesix (NASDAQ: BDSX) is $1.35 last updated June 27, 2022, 8:00 PM UTC.
There are no upcoming dividends for Biodesix.
Biodesix’s Q2 earnings are confirmed for Tuesday, August 9, 2022.
There is no upcoming split for Biodesix.
Biodesix is in the Health Care sector and Health Care Providers & Services industry. They are listed on the NASDAQ.